Kandi P. Xu
No. 1239 Siping Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Clinical outcomes and tumor immune microenvironment in SMARCA4-Deficient NSCLC: A Real-World retrospective study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 04, 2026
Major histocompatibility complex II serves as a prognostic biomarker in resectable pulmonary sarcomatoid carcinoma: development of a prediction model.
Journal: Translational lung cancer research
Published: January 26, 2026
Efficacy and safety of albumin-bound paclitaxel combined with simvastatin in the second-line treatment of small cell lung cancer: a phase II randomized controlled trial.
Journal: BMC medicine
Published: December 16, 2025
Analysis of paired primary-metastatic renal cancer lesions reveals RCN3-MMP10 axis facilitates lung metastasis.
Journal: Cellular signalling
Published: December 12, 2025
Multimodal multitask deep learning for grading management system in non-small cell lung cancer.
Journal: Nature communications
Published: June 27, 2025
Identification of DNA damage response and crotonylation-related biomarkers for lung adenocarcinoma via machine learning and WGCNA.
Journal: Clinical and experimental medicine
Published: March 26, 2025
A retrospective real-world single-arm study evaluating the efficacy and safety of neoadjuvant chemotherapy in patients with selected limited-stage small-cell lung cancer.
Journal: Translational lung cancer research
Published: February 26, 2025
Efficacy and safety of distinct regimens for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review and network meta-analysis.
Journal: Therapeutic advances in medical oncology
Published: February 12, 2025
HMOX1 expression influence the role of macrophage in EGFR-TKI resistance of lung adenocarcinoma.
Journal: International immunopharmacology
Published: January 31, 2025
What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysis.
Journal: BMC pulmonary medicine
Published: September 29, 2024
Efficacy and safety of first-line immunotherapy-based regimens for patients with extensive-stage small cell lung cancer: a systematic review and network meta-analysis.
Journal: Translational lung cancer research
Published: July 20, 2024
Last Updated: 09/26/2026